Are Oranges GMO? Facts on Genetically Modified Oranges

Oranges are not GMO. No genetically modified orange variety is grown commercially for fresh fruit or juice in the United States, and every orange on a grocery shelf today comes from conventional or traditionally bred citrus. That is starting to change underground, not on the branch. In April 2026, the Environmental Protection Agency approved CarriCea T1, a CRISPR gene-edited rootstock from the Florida biotech company Soilcea, built to fight the citrus greening disease that has devastated Florida’s groves. A rootstock is the root system a tree is grafted onto rather than the fruit-bearing variety itself, and the U.S. Department of Agriculture classifies the fruit that eventually grows on it as non-bioengineered.

Are Oranges GMO in the United States Today

No orange sold for fresh eating or juice in the United States today is genetically modified. Every commercial variety, from Valencia to navel to the small clementines sold as Cuties, comes from conventional breeding rather than gene splicing.

The Non-GMO Project, a nonprofit that verifies food labels, lists oranges among the crops people often mistake for genetically modified even though no commercial GMO orange has ever existed. Orange juice brands such as Tropicana carry Non-GMO labels, and the Genetic Literacy Project has pointed out that the claim is essentially meaningless when the only ingredient is oranges that were never engineered to begin with. A juice made from 100% orange content is non-GMO by default, whether the label says so or not. Mini clementines marketed as Cuties fall in the same category. They carry Non-GMO Project Verified marks, yet they reached their small, easy-peel shape through decades of traditional cross-breeding, the same method citrus growers have used for generations.

100% Orange Juice

100% Orange Juice

100% orange juice is made from oranges without added juice blends. It is commonly served chilled at breakfast, used in smoothies, or added to recipes. Compare not from concentrate and from concentrate options, pulp levels, pasteurized or fresh styles, and carton, bottle, or can packaging.

Check on Amazon

As an Amazon Associate we earn from qualifying purchases.

Why Citrus Greening Pushed Growers Toward Gene Editing

Citrus greening pushed growers toward gene editing because the disease has no cure and has already destroyed more than 90 percent of Florida’s commercial citrus production over the past two decades. Growers needed a way to keep trees alive, not just treat symptoms, and conventional tools were losing ground year after year.

How the Disease Spreads and What It Does

An insect called the Asian citrus psyllid spreads the bacterium behind the disease, Candidatus Liberibacter asiaticus, from tree to tree as it feeds. Once a tree is infected, its fruit turns green and sour instead of ripening normally, and the tree itself declines over a few years with no way to reverse the infection.

A single infected tree can serve as a source for psyllids that then carry the bacterium to healthy neighbors, so the disease tends to spread through a grove block by block rather than staying contained to one tree.

Why Earlier Control Methods Fell Short

Earlier control methods fell short because they targeted the insect and the symptoms rather than the bacterium’s ability to infect the tree in the first place. Growers leaned on regular insecticide sprays to knock back psyllid populations, and extension programs recommended removing infected trees to slow the spread to neighboring rows.

Both approaches bought time without solving the underlying problem, and groves kept losing productivity even where growers followed the guidance closely. That gap between managing the disease and actually resisting it is what made a genetic approach appealing once the science caught up.

The Toll on Florida’s Groves

Florida’s total citrus production in 2025-26 is 15.7 million boxes, up 13 percent from the previous season’s 13.85 million boxes. The final 2024-2025 Florida harvest included 12.15 million boxes of oranges, 1.3 million boxes of grapefruit, and 400,000 boxes of tangerines and tangelos.

What Is CarriCea T1

CarriCea T1 is a CRISPR gene-edited Carrizo orange rootstock developed by Soilcea, a Florida-based biotech company, and it is the first CRISPR-edited citrus product approved for commercial use in the United States. The Environmental Protection Agency approved it on April 28, 2026.

The University of Florida describes the approval as nearly a decade of collaboration between its researchers and Soilcea, built on work that began earlier. Dr. Nian Wang at the University of Florida began studying citrus greening resistance in 2008 and identified the genes that make orange trees susceptible to the disease. Soilcea was founded in 2014 to license that research and commercialize it, and the company achieved its first successful CRISPR edits in 2018.

Soilcea’s company timeline puts its first commercial-scale field trial in the ground in 2023, and the full path from Dr. Wang’s start on citrus greening in 2008 to the 2026 approval took about 18 years. Soilcea reports 54 positive and no negative comments during the regulatory review.

Why Soilcea Chose the Carrizo Rootstock

Soilcea built its edit into Carrizo citrange because growers already trust it. Carrizo is one of the most widely planted citrus rootstocks in commercial groves, valued for its vigor and its compatibility with common fruiting varieties such as Valencia and navel oranges. Editing a rootstock growers already know how to plant and manage removes one layer of risk from adoption, since farmers are not being asked to learn an unfamiliar variety at the same time they adjust to a new gene-edited product.

How CarriCea T1’s Gene Editing Works

CarriCea T1 is a citrus rootstock that makes precise edits to the citrus tree’s own existing genes rather than inserting DNA from other organisms. The edits disrupt the interaction between citrus plants and the bacteria that cause citrus greening, also called Huanglongbing or HLB.

EPA approved CarriCea T1 on April 28, 2026, under its plant-incorporated protectant framework. Soilcea says CarriCea T1 may help reduce reliance on certain conventional pesticide applications, but it is not intended to eliminate pest management programs entirely.

Is a Gene-Edited Rootstock the Same as a GMO Fruit

Not under current U.S. regulation. Because CarriCea T1’s edits only rework genes already present in the Carrizo rootstock instead of adding foreign DNA, regulators treat it differently than older transgenic GMOs that splice in genes from other organisms.

Why USDA Chose Not to Regulate It

USDA chose not to regulate the gene-edited orange because its Animal and Plant Health Inspection Service found no plausible pathway of increased plant pest risk from the edits. That determination, issued in October 2024, effectively cleared the plant of the extra oversight applied to older-style genetically engineered crops.

What EPA Approved and Why

The EPA approved CarriCea T1 specifically as a tool to help prevent widespread loss of citrus crops and support the country’s food supply. Soilcea markets the product as making precise edits to the tree’s own genes, and the agency’s own announcement frames the approval around reducing reliance on chemical sprays while helping groves survive an infection they could not otherwise fight off.

When Will Gene-Edited Oranges Reach Grocery Stores

Commercial shipments of CarriCea T1 began in 2026, but Soilcea says the age at which its CRISPR trees will provide commercial fruit yield is currently unknown. The company says fruit quality remains under evaluation; early fruit averaged 8.2 °Brix, and mature fruit was expected to reach 10-11 °Brix.

CarriCea T1 is a rootstock, not a fruiting variety. Citrus growers graft a fruiting variety onto a hardy rootstock, combining the variety above ground with the distinct rootstock below ground.

BeneCea D1 is Soilcea’s CRISPR-edited US-812 rootstock. The product is not registered and is currently in the regulatory review process.

EPA says fruit produced from CarriCea T1 rootstock will be indistinguishable from fruit produced using other rootstock varieties. Soilcea says USDA considers fruit from the rootstock non-bioengineered. FreshFruitPortal reported 300,000 rootstocks in production after commercial shipments began in July 2026.

USDA’s Animal and Plant Health Inspection Service determined it lacked authority over Soilcea’s gene-edited orange cultivar after finding no plausible pathway for increased plant-pest risk relative to comparator sweet-orange plants. EPA conducted a dietary safety assessment under its plant-incorporated protectant framework.

How to Read Non-GMO Labels on Orange Juice

A Non-GMO label on 100% orange juice is accurate, but it does not tell shoppers anything unique, because no commercial orange variety used for juice today is genetically modified to begin with. The label describes a fact that was already true before any verification process existed.

The controversy over this labeling dates back years. In 2017, the Genetic Literacy Project criticized Tropicana for using a Non-GMO label that implied competitors might contain genetically modified oranges, when in fact none did.

  1. Shoppers looking for meaningful label information on citrus products are better off checking for added sugar, preservatives, or juice-from-concentrate disclosures than searching for a GMO claim that no orange juice brand can honestly fail.
  2. I would pay more attention to the ingredient list and whether a product contains anything beyond oranges.

Beyond that, the new rootstock does not change that practical choice today, because consumer oranges remain non-GMO and the edited material is used below the fruit-bearing part of the tree.

My pet peeve is roundups that cite a roundup, a tidy little loop that can make a label seem more meaningful every time it is repeated. Here, the published check is simpler: when plain orange juice lists only oranges, a Non-GMO claim does not distinguish it from another plain juice, because genetically modified oranges are not on the market.

GMO Citrus Products at a Glance

Only one CRISPR-edited citrus product is commercially available as of September 2026: CarriCea T1. A second product, BeneCea D1, remains in development, and every fruit-bearing orange variety sold to consumers today is still non-GMO. The table below lines up what each product is, who makes it, and how far along it is toward reaching a working grove.

Product Type Company Regulatory Status Approval Date Commercial Status (September 2026)
CarriCea T1 CRISPR-edited Carrizo rootstock Soilcea EPA and USDA approved April 28, 2026 Commercially available; more than 300,000 trees in production
BeneCea D1 CRISPR-edited US 812 rootstock Soilcea In development Not yet approved Not commercialized
Consumer orange varieties Standard fruiting varieties Various growers Not genetically modified Not applicable Non-GMO

Frequently Asked Questions

Is CarriCea T1 the First GMO Citrus Product Ever Approved?

Yes. CarriCea T1 is the first CRISPR-edited citrus product approved for commercial use, receiving EPA approval on April 28, 2026, after a USDA determination in October 2024 found the plant did not need extra regulatory oversight. Earlier gene-edited citrus research existed, but none of it reached commercial approval before CarriCea T1.

Are Other Companies Developing GMO Oranges Besides Soilcea?

Public reporting as of September 2026 does not identify any other company with a commercially approved gene-edited orange program. Soilcea is the only firm behind both CarriCea T1 and the in-development BeneCea D1, and no competing commercial project has been announced elsewhere in the United States.

Is Fruit from CarriCea T1 Considered Bioengineered Under USDA Rules?

No. The USDA classifies fruit grown on CarriCea T1 rootstocks as non-bioengineered, because the CRISPR edits only rework genes the Carrizo rootstock already carries rather than inserting DNA from another organism. That distinction is why the plant avoids the regulatory category applied to older transgenic GMOs.

What Is BeneCea D1?

BeneCea D1 is Soilcea’s next CRISPR-edited rootstock, built on the USDA-developed US 812 citrus variety. It remained in development as of September 2026, with no approval date or commercial timeline announced yet.

Do Mini Clementines Like Cuties Count as GMO?

No. Cuties and similar mini clementines are Non-GMO Project Verified and reached their seedless, easy-peel form through traditional breeding, not genetic engineering. They are unrelated to Soilcea’s rootstock research and predate it by decades.

Does CarriCea T1 Reduce the Need for Pesticide Sprays?

Soilcea says it can. Because the edited trees limit the citrus greening bacterium largely on their own, the company expects growers to rely less on conventional pesticide sprays over time, though exact reductions will depend on how heavily a given grove was infected before switching rootstocks. Independent long-term data on spray reduction across commercial groves had not been published as of September 2026, so shoppers and growers alike will need to wait for a few full growing seasons before the real-world savings become clear.

For now, every orange in the produce aisle and every carton of orange juice on the shelf is non-GMO, and a Non-GMO label on citrus is accurate but redundant. The one place genuine gene editing has entered the picture is below ground, in a rootstock built to keep groves alive, and it will likely be a few more years before its effect on the fruit supply becomes clear.

Shoppers who want to track the story further can watch Soilcea’s own production numbers and the USDA’s future rulings on BeneCea D1, since those two markers will signal how fast gene-edited citrus moves from the nursery to the grocery aisle.

References

Sources read in September 2026.